Connection

Don Rockey to Disease Progression

This is a "connection" page, showing publications Don Rockey has written about Disease Progression.
Connection Strength

0.331
  1. Predictors of clinical outcomes in cirrhosis patients. Curr Opin Gastroenterol. 2018 07; 34(4):266-271.
    View in: PubMed
    Score: 0.117
  2. Gastrointestinal Bleeding Due to Gastrointestinal Tract Malignancy: Natural History, Management, and Outcomes. Dig Dis Sci. 2017 02; 62(2):491-501.
    View in: PubMed
    Score: 0.105
  3. Variability and Lability of Ammonia Levels in Healthy Volunteers and Patients With Cirrhosis: Implications for Trial Design and Clinical Practice. Am J Gastroenterol. 2020 05; 115(5):783-785.
    View in: PubMed
    Score: 0.033
  4. Hepatic fibrogenesis and hepatitis C. Semin Gastrointest Dis. 2000 Apr; 11(2):69-83.
    View in: PubMed
    Score: 0.033
  5. Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis. Gastroenterology. 2018 10; 155(4):1140-1153.
    View in: PubMed
    Score: 0.029
  6. Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection. J Transl Med. 2007 Jul 11; 5:33.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.